DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis

Publisher： Karger

E-ISSN： 1421-9662|120|1|11-13

ISSN： 0001-5792

Source： Acta Haematologica, Vol.120, Iss.1, 2008-08, pp. : 11-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 226-229

Karger

Access to resources Recommend Favorite

Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients

By Kwan Jonathan T. C.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 307-311

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

sTREM‐1 in patients with chronic kidney disease on hemodialysis

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 11, 2015-11 ,pp. : 969-974

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of DKD patients

By  

NEPHROLOGY, Vol. 20, Iss. 3, 2015-03 ,pp. : 155-160

John Wiley & Sons Inc

Access to resources Recommend Favorite